Udi # remain unknown.(b)(4).The article stated that two gore viabahn® endoprostheses were involved in the medical device incident.Multiple attempts have been made from the product surveillance coordinator to the author in order to get the lot numbers of the devices.As no further information related to this case has been or will be provided by the author, gore is submitting one report for the medical devices involved in the incident.Since the actual date of the incident is not available the year (january 1, 2016) when the patient was treated with the medical device was used as an estimated date of the incident.
|
Within the article ¿endovascular repair of 40 visceral artery aneurysms and pseudoaneurysms with the viabahn stent-graft: technical aspects, clinical outcome and mid-term patency¿, published by massimo venturini et al, within the (b)(6) 2017, clinical investigation abstract, accepted on november 13, 2017, the published results indicated the following: the purpose of this single-center study was to retrospectively report a 14-year experience with the peripheral, self-expandable viabahn stent-graft in the endovascular repair of 40 visceral artery aneurysms (vaa) and visceral artery pseudoaneurysms (vapa).As primary outcomes, peri-procedural complications, technical success 30-day clinical success, re-interventions and 30-day mortality were assessed.As secondary outcomes, stent-graft patency and persistent aneurysm devascularization at mid- (6¿12 months) and long-term (more than 12 months) were assessed.Patient b19 (male/(b)(6)) presented with a vapa within the middle gastroduodenal artery, which was treated with two gore® viabahn® endoprostheses (7 mm x 2,5 cm; 7 mm x 2,5 cm), where the approach was gained through the right femoral artery, in an emergency procedure 2016 suffered from a re-bleeding of the gastroduodenal artery stump which required a reintervention with a gore® viabahn® endoprosthesis.
|